Role of NAT2 deficiency in susceptibility to lung cancer among asbestos-exposed individuals

Pharmacogenetics

Volumn 10, Issue 2, 2000, Pages 183-185

  Saarikoski, Sirkku T ^a   Reinikainen, Maria ^a   Anttila, Sisko ^a   Karjalainen, Antti ^a   Vainio, Harri ^b   Husgafvel Pursiainen, Kirsti ^a   Hirvonen, Ari ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Asbestos; Genetic polymorphism; GSTM1; Lung cancer; NAT2; PCR

Indexed keywords

ACYLTRANSFERASE; ASBESTOS;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0034080902     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200003000-00010     Document Type: Article

References (15)

1. d'Errico A, Taioli E, Chen X, Vineis P. Genetic polymorphism and the risk of cancer: a review of the literature. Biomarkers 1996; 1:149-173.
2. Hirvonen A. Polymorphic NATs and cancer predisposition. In: Boffetta P, Caporaso N, Cuzick J, Lang M, Vineis P, editors. Metabolic polymorphisms and cancer. Lyon, France: International Agency for Research on Cancer; 1999, pp. 251-270.
3. Hirvonen A, Pelin K, Tammilehto L, Karjalainen A, Mattson K, Linnainmaa K. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res 1995; 55:2981-2983.
4. Hirvonen A, Saarikoski ST, Linnainmaa K, Koskinen K, Husgafvel-Pursiainen K, Mattson K, Vainio H. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 1996; 88:1853-1856.
5. IARC Scientific Publications. Mechanisms of fibre carcinogenesis, no. 140. Lyon, France: International Agency for Research on Cancer; 1996.
6. Jakobsson K, Rannug A, Alexandrie A-K, Warholm M, Rylander L, Hagmar L. Radiographic changes and lung function in relation to activity of the glutathione transferases theta and mu among asbestos cement workers. Tox Lett 1997; 77:363-369.
7. Kamp DW, Graceffa P, Pryor WA, Weitzman SA. The role of free radicals in asbestos-induced diseases. Free Rad Bio Med 1992; 12:293-315.
8. Karjalainen A, Anttila S, Vanhala E, Vainio H. Asbestos exposure and the risk of lung cancer in a general urban population. Scand J Work Environ Health 1994; 20:243-250.
9. Karjalainen A, Mönkkönen M, Vanhala E, Wolff H. Pulmonary fiber burden by occupation in Finland. Eur Resp J 1998; 12(suppl. 28):138.
10. Kelsey KT, Nelson HH, Wiencke JK, Smith CM, Levin S. The glutathione S-transferase theta and mu deletion polymorphisms in asbestosis. Am J Ind Med 1997; 31:274-279.
11. London SJ, Daly AK, Cooper J. Navidi WC, Carpenter CL, Idle JR. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles county, California. J Natl Cancer Inst 1995; 87:1246-1253.
12. McWilliams JE, Sanderson BJS, Harris EL, Richert-Boe KE, Henner WD. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 1995; 4:589-594.
13. Mossman BT, Gee JEL. Asbestos-related diseases. N Engl J Med 1989; 320:1721-1730.
14. Saarikoski ST, Voho A, Reinikainen M, Anttila S, Karjalainen A, Malaveille C, et al. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 1998; 77:516-521.
15. Smith CM, Kelsey KT, Wiencke JK. Leyden K, Levin S, Christiani DC. Inherited glutathione S-transferase deficiency is a risk factor for pulmonary asbestosis. Cancer Epidemiol Biomarkers Prev 1994; 3:471-477.